June 20, 2022
According to the business intelligence report titled ‘United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 - 2020 and Industry Forecast 2021 – 2027’, available with MarketStudyReport, United States self-monitoring blood glucose market is expected to surpass a valuation of USD 4.6 billion by 2027.
Expert researchers and analysts cite that increasing prevalence of diabetes among the masses, and rising geriatric population who are more susceptible to the disease are the major factors fostering United States self-monitoring blood glucose (SMBG) market growth.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3140355/
Moreover, noteworthy technological advancements in the field, combined with the advent of innovative, user-friendly products are likely to uncover new possibilities for market expansion during the forecast timeframe.
Apart from growth drivers and opportunities, the document highlights current and upcoming challenges that may hamper the growth dynamics of the industry, along with precise solutions to mitigate the impact. It also provides insights about the historical data as well as current trends to produce reliable estimates for growth rate, industry size, volume of sales, and revenue scope over the forecast period.
Furthermore, the research literature covers important aspects such as number of patients with diabetes and insulin users within United States, reimbursement patterns, and the prevalent regulatory system in the region.
Speaking of the competitive landscape, major contenders within this business sphere are thoroughly analyzed in terms of their product portfolio, company overview, and recent developments aimed at amplifying their profits.
The aforementioned aspects are scrutinized, providing insights into the evolving market landscape, thereby enabling the stakeholders to make informed decisions during the analysis timeframe.
Key players in United States self-monitoring blood glucose (SMBG) market scenario are Osang Healthcare Co. Ltd., Medtronic plc, i-SENS Inc., DarioHealth Corp., Genesis Health Technologies, Sanofi S.A., Simple Diagnostics, Walgreens Company, One Drop, B. Braun Holding GmbH & Co. KG, Omron Healthcare Co. Ltd., Arkray Inc., F. Hoffman-La Roche AG, Ascensia Diabetes Care, Abbot Diabetes Care Inc., Fifty 50 Medical LLC, LifeScan Inc., Oak Tree Health Care, Nova Diabetes Care, U.S. Diagnostics Inc., Philips BioTel Care, Prodigy Diabetes Care LLC, Omnis Health LLC, and Ypsomed Holding AG among others.